JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
PUT
Constellation Brands
STZ
$20.1B
| $1.42M | ﹤0.01% |
6,300
+2,500
| +66% | +$556K |
2021 Q3
6 quarters
|
|
3627
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.73B
| $1.42M | ﹤0.01% |
31,032
-27,172
| -47% | -$1.25M |
2017 Q2
23 quarters
|
|
3628
Invesco S&P 500 Low Volatility ETF
SPLV
$7B
| $1.42M | ﹤0.01% |
22,768
-21,842
| -49% | -$1.36M |
2013 Q2
39 quarters
|
|
|
ADAP
3629
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.42M | ﹤0.01% |
1,303,843
+302,731
| +30% | +$469K |
2016 Q3
26 quarters
|
|
3630
Vanda Pharmaceuticals
VNDA
$275M
| $1.41M | ﹤0.01% |
207,872
-13,412
| -6% | -$94.3K |
2015 Q4
29 quarters
|
|
3631
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
| $1.41M | ﹤0.01% |
13,098
+497
| +4% | +$54.1K |
2013 Q2
39 quarters
|
|
3632
CALL
Intercontinental Exchange
ICE
$85.6B
| $1.41M | ﹤0.01% |
13,500
-37,700
| -74% | -$3.93M |
2018 Q2
19 quarters
|
|
3633
1st Source
SRCE
$2.03B
| $1.41M | ﹤0.01% |
32,583
+5,445
| +20% | +$266K |
2013 Q2
39 quarters
|
|
3634
CALL
Inspire Medical Systems
INSP
$1.95B
| $1.4M | ﹤0.01% |
+6,000
| New | +$1.52M |
2023 Q1
0 quarters
|
|
3635
MasterBrand
MBC
$1.4B
| $1.4M | ﹤0.01% |
174,667
-294,657
| -63% | -$2.6M |
2022 Q4
1 quarter
|
|
3636
Krispy Kreme
DNUT
$503M
| $1.4M | ﹤0.01% |
89,983
+17,798
| +25% | +$231K |
2021 Q3
6 quarters
|
|
3637
Montauk Renewables
MNTK
$376M
| $1.4M | ﹤0.01% |
177,298
+26,379
| +17% | +$268K |
2021 Q1
8 quarters
|
|
|
RWT
3638
Redwood Trust
RWT
$418M
| $1.39M | ﹤0.01% |
206,738
-366,521
| -64% | -$2.75M |
2013 Q2
39 quarters
|
|
|
TSE
3639
DELISTED
Trinseo
TSE
| $1.39M | ﹤0.01% |
66,789
-8,732
| -12% | -$214K |
2015 Q2
31 quarters
|
|
|
SPR
3640
CALL
DELISTED
Spirit AeroSystems
SPR
| $1.39M | ﹤0.01% |
40,200
+3,400
| +9% | +$114K |
2022 Q4
1 quarter
|
|
3641
PUT
PG&E
PCG
$38.4B
| $1.39M | ﹤0.01% |
85,800
+80,000
| +1,379% | +$1.26M |
2022 Q3
2 quarters
|
|
3642
CALL
DuPont de Nemours
DD
$17.7B
| $1.39M | ﹤0.01% |
15,376
-17,287
| -53% | -$1.58M |
2021 Q3
6 quarters
|
|
3643
Nkarta
NKTX
$163M
| $1.38M | ﹤0.01% |
389,358
+4,815
| +1% | +$22.8K |
2020 Q3
10 quarters
|
|
3644
CALL
Airbnb
ABNB
$94.8B
| $1.38M | ﹤0.01% |
11,100
-50,100
| -82% | -$5.72M |
2022 Q3
2 quarters
|
|
3645
Core & Main
CNM
$7.49B
| $1.38M | ﹤0.01% |
59,790
+16,728
| +39% | +$368K |
2021 Q3
6 quarters
|
|
|
LX
3646
LexinFintech Holdings
LX
$119M
| $1.38M | ﹤0.01% |
509,319
+162,286
| +47% | +$469K |
2019 Q4
13 quarters
|
|
3647
Equinor
EQNR
$98.9B
| $1.38M | ﹤0.01% |
48,504
+33,958
| +233% | +$1.02M |
2013 Q2
39 quarters
|
|
3648
ALPS Clean Energy ETF
ACES
$98.7M
| $1.38M | ﹤0.01% |
29,591
+29,504
| +33,913% | +$1.42M |
2022 Q4
1 quarter
|
|
3649
Enact Holdings
ACT
$6.31B
| $1.37M | ﹤0.01% |
60,056
+27,830
| +86% | +$662K |
2021 Q4
5 quarters
|
|
3650
Sierra Bancorp
BSRR
$509M
| $1.37M | ﹤0.01% |
79,754
+957
| +1% | +$19.2K |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.